Baxter International Inc.

Last updated September 27, 2026

Organization details

Legal name
Baxter International Inc.
Ownership
Public
Status
Active
SIC code
3841 — Surgical & Medical Instruments & Apparatus
Jurisdiction of incorporation
Delaware
Headquarters city
Deerfield
Headquarters state / province
Illinois
Headquarters country
United States
Fiscal year end
December
Ticker symbol
BAX
Primary stock exchange
NYSE

Identifiers

SEC CIK
0000010456
EIN
36-0781620

Board of directors

Chief executives

Andrew P. Hider · President and CEO
Since August 2025

Director election results

Annual meeting of May 4, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

11 of this board's directors also sit on 19 other boards.

Network of Baxter International Inc.'s board connections Boston Scientific Corporation Boston Scientific Corp... Amerant Bancorp Inc. Amerant Bancorp Inc. Arcosa Inc. Arcosa Inc. Axogen Inc. Axogen Inc. CVS Health Corporation CVS Health Corporation Encompass Health Corporation Encompass Health Corpo... Hyliion Holdings Corp. Hyliion Holdings Corp. LivaNova PLC LivaNova PLC Merit Medical Systems Inc. Merit Medical Systems... Moderna Inc. Moderna Inc. Oracle Corporation Oracle Corporation PPG Industries Inc. PPG Industries Inc. Quest Diagnostics Incorporated Quest Diagnostics Inco... Shoals Technologies Group Inc. Shoals Technologies Gr... Solventum Corporation Solventum Corporation Tactile Systems Technology Inc. Tactile Systems Techno... Amy McBride Wendell Amy McBride Wendell Cathy R. Smith Cathy R. Smith David Brent Shafer David Brent Shafer Jeffrey A. Craig Jeffrey A. Craig Michael F. Mahoney Michael F. Mahoney Michael R. McDonnell Michael R. McDonnell Nancy M. Schlichting Nancy M. Schlichting Patricia Morrison Patricia Morrison Peter M. Wilver Peter M. Wilver Stephen H. Rusckowski Stephen H. Rusckowsk... Baxter International Inc.
Shared director Other board Same sector +3 more in the list below

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$0
0 purchases by 0 insiders
Sold, last 12 months
$0
0 sales by 0 insiders
Date Insider Transaction Shares Price Value
Sep 2, 2026 Foster Julie Officer (President, Front Line Care) Shares withheld for tax −2,098 $25.70 $53,919
Sep 2, 2026 Andrew P. Hider Director, Officer (President and CEO) Shares withheld for tax −54,276 $25.70 $1,394,893
Sep 1, 2026 Teaff James Officer (President, CCS) Shares withheld for tax −750 $25.48 $19,110
Jun 2, 2026 Wallace Steven P. Officer (President, Adv. Surgery) Shares withheld for tax −153 $18.68 $2,858
Jun 2, 2026 Teaff James Officer (President, CCS) Shares withheld for tax −321 $18.68 $5,996
Jun 1, 2026 Zielinski Anita A Officer (SVP, Interim CFO, CAO & Cntrlr) Grant or award +13,426 — —
May 5, 2026 David S. Wilkes Director Grant or award +12,836 — —
May 5, 2026 Amy McBride Wendell Director Grant or award +12,836 — —
May 5, 2026 Nancy M. Schlichting Director Grant or award +12,836 — —
May 5, 2026 Patricia Morrison Director Grant or award +12,836 — —
May 5, 2026 David Brent Shafer Director, Chair of the Board Grant or award +12,836 — —
May 5, 2026 Michael R. McDonnell Director Grant or award +12,836 — —
May 5, 2026 Jeffrey A. Craig Director Grant or award +12,836 — —
May 5, 2026 William A. Ampofo II Director Grant or award +12,836 — —
Mar 6, 2026 Zielinski Anita A Officer (SVP, CAO and Controller) Shares withheld for tax −1,932 $17.69 $34,177

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.